For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240426:nRSZ2650Ma&default-theme=true
RNS Number : 2650M Primary Health Properties PLC 26 April 2024
Primary Health Properties PLC
("PHP" or the "Company"),
Director/PDMR Shareholding
On 26 April 2024, the following executive director was granted options to
subscribe for new ordinary shares of 12.5 pence each in Primary Health
Properties PLC (the "Company" or "PHP") at a price of £0.7308 per share under
the Company's 2024 Sharesave Plan, exercisable from May 2027 following the
close of the associated three-year savings contract.
Details of the transaction referenced above are included below in accordance
with Article 19 of the retained EU law version of the Market Abuse Regulation
(Regulation 596/2014).
1 Details of person discharging managerial responsibilities/person closely
associated
(a) Name Mark Davies
2 Reason for notification
(a) Position/Status Chief Executive Officer
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
(a) Description of the financial instrument Ordinary shares of 12.5p
ISIN: GB00BYRJ5J14
(b) Nature of the transaction Award of options over the Company's ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
£0.7308 25,383
(d) Aggregated volume price Single transaction: N/A
(e) Date of transaction 26 April 2024
(f) Place of transaction n/a
For further information
Primary Health Properties PLC
Toby Newman, Company Secretary & Chief Legal Officer
+44(0) 7729 047 959
Legal Entity Identifier: 213800Y5CJHXOATK7X11
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBXGDSIBDDGSL